Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Hinge Health, Inc.
HNGE
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $6.6B
$84.05
▼ -1.20%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$30.08 - $86.66
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 90.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI-powered clinical platform and patient engagement technology
- Established relationships with major employers and health plans
- Comprehensive clinical team combining software engineering with healthcare expertise
- Strong brand recognition in the musculoskeletal care digital health space
Bear Case
2 risks
- Above-average volatility (beta 2.0).
- Premium valuation to Healthcare IT & Services peers
Growth
Turning profitable
Increasing employer demand for cost-effective musculoskeletal care solutions
Value
Premium valuation to Healthcare IT & Services peers
Momentum
Hot
+118.2% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HNGE right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 4, 2026
MAY 5, 2026
Reported EPS of $0.45 vs $0.39 consensus (+15.4% surprise). Revenue of $182.3M vs $172.2M expected (+5.9%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+15.4%
Next: Aug 4, 2026
Revenue trend · last 8Q
—
—
—
+50%
+55%
+53%
+46%
+47%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$89.8M
$100.6M
$117.3M
$123.8M
$139.1M
$154.2M
$170.7M
$182.3M
Margins · last 8Q
Gross
—
Operating
—
Profit
19.3%
Wall Street consensus
11 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$64.00
▼ -23.9% vs $84.05
Latest: Wells Fargo · Jun 23, 2026
8 analysts covering